NCT00942409 - Study of Repeat Intranodal Injections of Ad-ISF35 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2014

Conditions

Non-Hodgkin's LymphomaFollicular LymphomaDiffuse Large Cell LymphomaMantle Cell LymphomaSmall Lymphocytic LymphomaChronic Lymphocytic Leukemia

Interventions

BIOLOGICAL

ISF35

Subjects participating in this study will be treated with multiple doses of Ad-ISF35 given via intranodal injection using a fixed dose of 3.3 x 10\^10 ISF35 viral particles. Intranodal injections will be administered every 2-4 weeks up to six total injections.

Trial Locations (1)

92093

University of California, San Diego Moores Cancer Center, La Jolla